Shuttle Pharmaceuticals Holdings, Inc. (SHPH): Nasdaq/NYSE listing notice — Shuttle Pharma receives additional 180-day Nasdaq grace period through Aug 2024 for bid price compliance

Shuttle Pharmaceuticals Holdings, Inc.

Nasdaq granted additional 180-day grace period until Aug 26, 2024 to regain $1.00 minimum bid price compliance.
Company submitted Plan of Compliance including potential reverse stock split if needed.
Initial 180-day grace period ended Feb 27, 2024; company had not yet regained compliance.
CEO Dr. Anatoly Dritschilo to present at Emerging Growth Conference on March 6, 2024.
If compliance not met by Aug 26, 2024, Nasdaq will delist; appeal possible.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Shuttle Pharmaceuticals Holdings, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 29, 2024, the Company received formal approval from Nasdaq granting it an additional 180 days, or until August 26, 2024 (the “Compliance Date”), to regain compliance with the Bid Price Requirement. If at any time before the Compliance Date the closing bid price for the Company’s common stock is at least $1.00 for a minimum of 10 consecutive business days, the Staff will provide the Company written confirmation that it has regained compliance with the Bid Price Requirement. If the Company does not regain compliance with the Bid Price Requirement by the Compliance Date, the Staff will p

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Shuttle Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-008796

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.